168 related articles for article (PubMed ID: 25856229)
1. A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits.
Massari S; Nannetti G; Desantis J; Muratore G; Sabatini S; Manfroni G; Mercorelli B; Cecchetti V; Palù G; Cruciani G; Loregian A; Goracci L; Tabarrini O
J Med Chem; 2015 May; 58(9):3830-42. PubMed ID: 25856229
[TBL] [Abstract][Full Text] [Related]
2. 1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors.
Pismataro MC; Felicetti T; Bertagnin C; Nizi MG; Bonomini A; Barreca ML; Cecchetti V; Jochmans D; De Jonghe S; Neyts J; Loregian A; Tabarrini O; Massari S
Eur J Med Chem; 2021 Oct; 221():113494. PubMed ID: 33962311
[TBL] [Abstract][Full Text] [Related]
3. Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity.
Desantis J; Nannetti G; Massari S; Barreca ML; Manfroni G; Cecchetti V; Palù G; Goracci L; Loregian A; Tabarrini O
Eur J Med Chem; 2017 Sep; 138():128-139. PubMed ID: 28666191
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase.
Massari S; Bertagnin C; Pismataro MC; Donnadio A; Nannetti G; Felicetti T; Di Bona S; Nizi MG; Tensi L; Manfroni G; Loza MI; Sabatini S; Cecchetti V; Brea J; Goracci L; Loregian A; Tabarrini O
Eur J Med Chem; 2021 Jan; 209():112944. PubMed ID: 33328103
[TBL] [Abstract][Full Text] [Related]
6. Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics.
Massari S; Goracci L; Desantis J; Tabarrini O
J Med Chem; 2016 Sep; 59(17):7699-718. PubMed ID: 27046062
[TBL] [Abstract][Full Text] [Related]
7. Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus.
Kessler U; Castagnolo D; Pagano M; Deodato D; Bernardini M; Pilger B; Ranadheera C; Botta M
Bioorg Med Chem Lett; 2013 Oct; 23(20):5575-7. PubMed ID: 24012120
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.
Matusevich OV; Egorov VV; Gluzdikov IA; Titov MI; Zarubaev VV; Shtro AA; Slita AV; Dukov MI; Shurygina AP; Smirnova TD; Kudryavtsev IV; Vasin AV; Kiselev OI
Antiviral Res; 2015 Jan; 113():4-10. PubMed ID: 25446335
[TBL] [Abstract][Full Text] [Related]
9. 4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling.
Trist IM; Nannetti G; Tintori C; Fallacara AL; Deodato D; Mercorelli B; Palù G; Wijtmans M; Gospodova T; Edink E; Verheij M; de Esch I; Viteva L; Loregian A; Botta M
J Med Chem; 2016 Mar; 59(6):2688-703. PubMed ID: 26924568
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction.
D'Agostino I; Giacchello I; Nannetti G; Fallacara AL; Deodato D; Musumeci F; Grossi G; Palù G; Cau Y; Trist IM; Loregian A; Schenone S; Botta M
Eur J Med Chem; 2018 Sep; 157():743-758. PubMed ID: 30142611
[TBL] [Abstract][Full Text] [Related]
11. Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance.
Nannetti G; Massari S; Mercorelli B; Bertagnin C; Desantis J; Palù G; Tabarrini O; Loregian A
Antiviral Res; 2019 May; 165():55-64. PubMed ID: 30885750
[TBL] [Abstract][Full Text] [Related]
12. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
[TBL] [Abstract][Full Text] [Related]
13. Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly.
Massari S; Nannetti G; Goracci L; Sancineto L; Muratore G; Sabatini S; Manfroni G; Mercorelli B; Cecchetti V; Facchini M; Palù G; Cruciani G; Loregian A; Tabarrini O
J Med Chem; 2013 Dec; 56(24):10118-31. PubMed ID: 24313730
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the N-terminal portion of influenza virus RNA polymerase subunit PB1 in nucleotide recognition.
Binh NT; Wakai C; Kawaguchi A; Nagata K
Biochem Biophys Res Commun; 2014 Jan; 443(3):975-9. PubMed ID: 24361882
[TBL] [Abstract][Full Text] [Related]
15. Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
Mizuta S; Otaki H; Ishikawa T; Makau JN; Yamaguchi T; Fujimoto T; Takakura N; Sakauchi N; Kitamura S; Nono H; Nishi R; Tanaka Y; Takeda K; Nishida N; Watanabe K
J Med Chem; 2022 Jan; 65(1):369-385. PubMed ID: 34905383
[TBL] [Abstract][Full Text] [Related]
16. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.
Watanabe K; Ishikawa T; Otaki H; Mizuta S; Hamada T; Nakagaki T; Ishibashi D; Urata S; Yasuda J; Tanaka Y; Nishida N
Sci Rep; 2017 Aug; 7(1):9500. PubMed ID: 28842649
[TBL] [Abstract][Full Text] [Related]
17. Mapping the domain structure of the influenza A virus polymerase acidic protein (PA) and its interaction with the basic protein 1 (PB1) subunit.
Guu TS; Dong L; Wittung-Stafshede P; Tao YJ
Virology; 2008 Sep; 379(1):135-42. PubMed ID: 18657841
[TBL] [Abstract][Full Text] [Related]
18. Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.
Li C; Wang Z; Cao Y; Wang L; Ji J; Chen Z; Deng T; Jiang T; Cheng G; Qin FX
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031371
[TBL] [Abstract][Full Text] [Related]
19. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
20. Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics.
Zhou Z; Liu T; Zhang J; Zhan P; Liu X
Drug Discov Today; 2018 Mar; 23(3):503-518. PubMed ID: 29339107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
